By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Menlo Therapeutics Inc 

4085 Campbell Avenue
Suite 200
Menlo Park  California  CA 94025  U.S.A.
Phone: 650-486-1416 Fax:


SEARCH JOBS

Menlo Therapeutics Inc. (formerly Tigercat Pharma, Inc.) is a clinical stage pharmaceutical company focused on the development and commercialization of serlopitant for the treatment of severe, chronic pruritus (itch). Serlopitant (VPD-737) is a potent oral NK1 receptor antagonist that Menlo Therapeutics exclusively licensed from Merck in 2012. Menlo Therapeutics investors include Vivo Capital, F-Prime Capital, Presidio Partners and Remeditex Ventures.

YEAR FOUNDED:

2011

LEADERSHIP:

CEO: Steven Basta

CMO: Paul Kwon


Key Statistics


Email: info@menlotx.com
Ownership: Private

Web Site: Menlo Therapeutics
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->